Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy-Reference-Cited by-同舟云学术

Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy

Published:2019-07-29 Issue:10 Volume:18 Page:1775-1786
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Zheng Lin,Chen Zibo,Kawakami Masanori,Chen Yulong,Roszik Jason^ORCID,Mustachio Lisa Maria,Kurie Jonathan M.,Villalobos Pamela,Lu Wei,Behrens Carmen,Mino Barbara,Solis Luisa M.^ORCID,Silvester Jennifer,Thu Kelsie L.,Cescon David W,Rodriguez-Canales Jaime,Wistuba Ignacio I.,Mak Tak W.,Liu Xi,Dmitrovsky Ethan

Funder

HHS | NIH | National Cancer Institute (NCI)

Samuel Waxman Cancer Research Foundation (SWCRF)

university of texas STARs

American Cancer Society (ACS)

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hijacking monopolar spindle 1 (MPS1) for various cancer types by small molecular inhibitors: Deep insights from a decade of research and patents;European Journal of Medicinal Chemistry;2024-07

2. Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation;BMC Complementary Medicine and Therapies;2024-05-23

3. The two sides of chromosomal instability: drivers and brakes in cancer;Signal Transduction and Targeted Therapy;2024-03-29

4. Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer;Molecular Therapy: Oncology;2024-03

5. Maximizing Anticancer Response with MPS1 and CENPE Inhibition Alongside Apoptosis Induction;Pharmaceutics;2023-12-29